John C. Davis, Jr.
2019
In 2019, John C. Davis, Jr. earned a total compensation of $913.5K as Head of Research and Development and Chief Medical Officer at Dianthus Therapeutics, a 71% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $150,120 |
|---|---|
| Option Awards | $345,899 |
| Salary | $417,000 |
| Other | $502 |
| Total | $913,521 |
Davis received $417K in salary, accounting for 46% of the total pay in 2019.
Davis also received $150.1K in non-equity incentive plan, $345.9K in option awards and $502 in other compensation.
Rankings
In 2019, John C. Davis, Jr.'s compensation ranked 9,690th out of 13,971 executives tracked by ExecPay. In other words, Davis earned more than 30.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,690 out of 13,971 | 31st |
Division Manufacturing | 3,904 out of 5,701 | 32nd |
Major group Chemicals And Allied Products | 1,488 out of 2,200 | 32nd |
Industry group Drugs | 1,272 out of 1,886 | 33rd |
Industry Pharmaceutical Preparations | 945 out of 1,398 | 32nd |
Source: SEC filing on April 21, 2021.
Davis' colleagues
We found one more compensation record of an executive who worked with John C. Davis, Jr. at Dianthus Therapeutics in 2019.
2019
Jason Gardner
Dianthus Therapeutics